EichorEICHOR
Study identifier: NCT06074562 Synced from ClinicalTrials.gov · August 02, 2026
● Completed

A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Condition: Diabetic Peripheral Neuropathy  ·  Sponsor: Eli Lilly and Company

PhasePhase 2
Planned participants404
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The main purpose of this study is to determine the safety and efficacy of LY3556050 versus placebo in participants with diabetic peripheral neuropathic pain (DPNP). The study will lasts approximately 24 weeks, across 3 study periods.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (70)

The Institute for Liver Health II dba Arizona Clinical Trials - MesaChandler, Arizona, United States
Headlands Research - ScottsdaleScottsdale, Arizona, United States
Orange Grove Family PracticeTucson, Arizona, United States
Preferred Research PartnersLittle Rock, Arkansas, United States
Hope Clinical Research, Inc.Canoga Park, California, United States
Valley Clinical Trials, Inc.Northridge, California, United States
Northern California Research - SacramentoSacramento, California, United States
CMR of Greater New Haven, LLCHamden, Connecticut, United States
Suncoast Research GroupMiami, Florida, United States
New Horizon Research CenterMiami, Florida, United States
Northwestern UniversityChicago, Illinois, United States
Alliance for Multispecialty Research, LLCWichita, Kansas, United States

+ 58 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →